Effect of certain drugs on perfused human placenta. V. Use of alpha and beta adrenergic blocking agents to determine the specific effector site of vasoactive substances.
D000328:Adult; D004232:Diuretics / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D009566:Nitrates / Q000494:pharmacology; D009573:Nitrites / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology; D010121:Oxytocin / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology*; D010920:Placenta / Q000187:drug effects*; D013566:Sympathomimetics / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects*; D014667:Vasopressins / Q000494:pharmacology
D004232:Diuretics; D009566:Nitrates; D009573:Nitrites; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D014667:Vasopressins; D010121:Oxytocin; D010208:Papaverine; D005996:Nitroglycerin; D007545:Isoproterenol; D004837:Epinephrine; D010646:Phentolamine